AR124044A1 - Cápsulas blandas de liberación retardada - Google Patents

Cápsulas blandas de liberación retardada

Info

Publication number
AR124044A1
AR124044A1 ARP210103126A ARP210103126A AR124044A1 AR 124044 A1 AR124044 A1 AR 124044A1 AR P210103126 A ARP210103126 A AR P210103126A AR P210103126 A ARP210103126 A AR P210103126A AR 124044 A1 AR124044 A1 AR 124044A1
Authority
AR
Argentina
Prior art keywords
coating composition
dependent
glycerin
sorbitol
delayed
Prior art date
Application number
ARP210103126A
Other languages
English (en)
Spanish (es)
Inventor
Karunakar Sukuru
Qi Fang
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of AR124044A1 publication Critical patent/AR124044A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ARP210103126A 2020-11-11 2021-11-11 Cápsulas blandas de liberación retardada AR124044A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202063112456P 2020-11-11 2020-11-11

Publications (1)

Publication Number Publication Date
AR124044A1 true AR124044A1 (es) 2023-02-08

Family

ID=81601781

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210103126A AR124044A1 (es) 2020-11-11 2021-11-11 Cápsulas blandas de liberación retardada

Country Status (13)

Country Link
US (1) US20230404927A1 (cg-RX-API-DMAC7.html)
EP (1) EP4243786A4 (cg-RX-API-DMAC7.html)
JP (2) JP7830458B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230106641A (cg-RX-API-DMAC7.html)
CN (1) CN116685311A (cg-RX-API-DMAC7.html)
AR (1) AR124044A1 (cg-RX-API-DMAC7.html)
AU (1) AU2021377907A1 (cg-RX-API-DMAC7.html)
CA (1) CA3197516A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023007156A2 (cg-RX-API-DMAC7.html)
IL (1) IL302751A (cg-RX-API-DMAC7.html)
MX (1) MX2023005450A (cg-RX-API-DMAC7.html)
TW (1) TW202233165A (cg-RX-API-DMAC7.html)
WO (1) WO2022104338A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102022104553A1 (de) * 2022-02-25 2023-08-31 Gelita Ag Magensaftresistente Kapsel und deren Verwendung
AU2023292098A1 (en) * 2022-06-13 2025-01-16 R.P. Scherer Technologies, Llc Enteric bisacodyl softgel capsule
KR102785453B1 (ko) * 2022-06-21 2025-03-26 우리바이오(주) 장용성 연질 캡슐용 겔 매스 조성물
WO2024035910A1 (en) * 2022-08-12 2024-02-15 R.P. Scherer Technologies, Llc Coated enteric softgel capsules
AU2023397554B2 (en) 2022-12-14 2026-01-29 R.P. Scherer Technologies, Llc Softgel capsules and a method for preparing the softgel capsules
JPWO2025009342A1 (cg-RX-API-DMAC7.html) * 2023-07-03 2025-01-09
CN120436302A (zh) * 2024-02-08 2025-08-08 仙乐健康科技(广东)有限公司 一种果胶凝胶及其制备方法
WO2025234509A1 (ko) * 2024-05-08 2025-11-13 코스맥스바이오 주식회사 pH 의존성 필름 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0427352A (ja) * 1990-05-22 1992-01-30 Fuji Capsule Kk 健康食品用腸溶性軟カプセル
US5342626A (en) * 1993-04-27 1994-08-30 Merck & Co., Inc. Composition and process for gelatin-free soft capsules
US6340473B1 (en) * 1999-07-07 2002-01-22 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
US20120301546A1 (en) 2011-05-26 2012-11-29 Hassan Emadeldin M Acid-resistant soft gel compositions
TW201343203A (zh) * 2011-12-22 2013-11-01 普諾華生物製藥諾治股份有限公司 含有ω-3脂肪酸之經明膠/藻酸鹽延緩釋放型膠囊,其製法及用途
MX2014011139A (es) * 2012-04-13 2015-07-17 Banner Life Sciences Llc Cápsulas elásticas blandas que contienen comprimidos y rellenos líquidos o semisólidos y métodos para su fabricacion.
WO2015200149A1 (en) * 2014-06-23 2015-12-30 Banner Life Sciences Llc All natural enteric soft capsules comprising active ingredients
MY184967A (en) 2014-10-06 2021-04-30 Fuji Capsule Co Ltd Method of producing enteric soft capsule
US10711119B2 (en) * 2018-01-10 2020-07-14 Cp Kelco Aps Carrageenan-based compositions for films and capsules
EP3768094B1 (en) 2018-03-15 2024-05-01 R.P. Scherer Technologies, LLC Enteric softgel capsules

Also Published As

Publication number Publication date
KR20230106641A (ko) 2023-07-13
JP2023549177A (ja) 2023-11-22
WO2022104338A1 (en) 2022-05-19
CO2023007156A2 (es) 2023-06-20
IL302751A (en) 2023-07-01
US20230404927A1 (en) 2023-12-21
EP4243786A1 (en) 2023-09-20
TW202233165A (zh) 2022-09-01
JP2026086913A (ja) 2026-05-26
CN116685311A (zh) 2023-09-01
MX2023005450A (es) 2023-05-23
EP4243786A4 (en) 2024-10-23
AU2021377907A1 (en) 2023-06-15
CA3197516A1 (en) 2022-05-19
JP7830458B2 (ja) 2026-03-16

Similar Documents

Publication Publication Date Title
AR124043A1 (es) Cápsulas blandas de liberación retardada
CO2023007156A2 (es) Cápsulas de gel blando de liberación retardada
MX2022013695A (es) Composicion encapsulada de microcapsulas de nucleo-cubierta y proceso para su preparacion.
PE20061136A1 (es) Sistema de capsulas blandas que no son de gelatina
AR115269A1 (es) Cápsulas de gelatina blanda entéricas
AR119075A1 (es) Cápsulas blandas de liberación diferida
AR100519A1 (es) Envase tipo cápsula de gelatina blanda y su método de fabricación
JP2022535539A5 (cg-RX-API-DMAC7.html)
DOP2012000217A (es) Pastillas de gelatina blanda con nicotina
DK1898889T3 (da) Brudbar, samlingsløs gellankapsel og en proces til fremstilling heraf
AR122512A1 (es) Cápsulas blandas de liberación retardada
BRPI0707334B8 (pt) formulação de cápsula de gelatina mole de um composto 15-ceto-prostaglandina e método para estabilização do um composto 15-cetoprostaglandina
MX2022005050A (es) Cápsulas de gelatina blanda de liberación retardada en entorno de ph más alto.
WO2012097429A8 (en) Probiotic soft gel compositions
JP2022554247A5 (cg-RX-API-DMAC7.html)
BR112023020963A2 (pt) Composição, método para encapsular microesferas liofilizadas, sistema e método para o controle da liberação de microesferas encapsuladas
JP2023549177A5 (cg-RX-API-DMAC7.html)
AR114434A1 (es) Cápsulas de gelatina blanda entéricas
AR117242A1 (es) Cápsulas basadas en almidón de alta amilosa y método para preparar las mismas
AR123805A1 (es) Cápsulas blandas de liberación modificada
JP2023532180A5 (cg-RX-API-DMAC7.html)
MX2021010959A (es) Estabilidad mejorada de ingredientes farmaceuticos activos (api) en capsulas blandas.
AR062374A1 (es) Metodo para prevenir la cristalizacion
AR087032A1 (es) Composiciones de capsulas de gelatina y metodos para fabricarlas
MX2021010276A (es) Procedimiento para llenar recipientes con polvo.